Skip to main content

HTRF Human IgG Kappa MAb Detection Kit, 500 Assay Points

The Human IgG Kappa MAb kit is designed for the fast quantification of human IgGs Kappa light chains.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

Product Variants
Part number: 64KAPPEG
Unit Size: 500 Assay Points
List price: USD 778.36
Your price:
USD 778.36
USD 778.36 /each
Part number: 64KAPPEH
Unit Size: 10,000 Assay Points
List price: USD 6,819.00
Your price:
USD 0.00
USD 6,819.00 /each


Drug discovery and bioprocess often require accurate quantification technologies to improve the productivity workflow. Current methods such as ELISA do not properly fit with such objectives as they require multiple sample-handling and protocol steps. The human IgG Kappa MAb kit enables a rapid quantification of human IgG Kappa light chains in cell supernatant. The assay is compatible with natural IgG as well as recombinant antibodies.


Assay Points
Assay Target Type
Assay Technology
Therapeutic Area
Infectious Diseases
Rare Diseases
Unit Size
500 Assay Points

Video gallery

How it works

Assay principle

The human IgG Kappa MAb kit is detected in a sandwich assay format using 2 different specific antibodies. The anti-(h)-IgG Kappa antibody is labelled with d2 (acceptor) and the anti(h)-Fc antibody is labelled with Eu3+-Cryptate (donor). The two antibodies bind to the (h)IgG Kappa present in the sample, thereby generating FRET. The specific signal modulates positively in proportion to (h)IgG Kappa.



Assay protocol

The human IgG Kappa MAb assay features a streamlined protocol with only 1 incubation step after sample and IgG Kappa MAb detection reagents dispensing. This protocol requires a single two-hour incubation period at RT.



Assay details

Key features
Detection limit 0.8 ng/mL
Dynamic range 0.8 to 100 ng/mL
Specificity subclasses IgG1, IgG2, IgG3 & IgG4
Cross reactivity 0% Human Lambda
0% Mouse Kappa
<1% Human IgM



1-2 of 2 Resources
Whitepaper Icon
Antibody-based therapeutic modalities in oncology

With over 200 different types of cancer, management relies on a variety of techniques such as chemotherapy, radiotherapy, and...

Guide Icon
HTRF solutions, guide to major applications

This guide provides you an overview of HTRF applications in several therapeutic areas.

SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon